{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:25:50Z","timestamp":1788690350475,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012494","name":"Chongqing Municipal Education Commission Foundation","doi-asserted-by":"publisher","award":["[2021]27-KJQN202100455"],"award-info":[{"award-number":["[2021]27-KJQN202100455"]}],"id":[{"id":"10.13039\/100012494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2023GDRC015"],"award-info":[{"award-number":["2023GDRC015"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-024-01483-0","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T08:02:30Z","timestamp":1728028950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn\u2019s disease patients in western China"],"prefix":"10.1007","volume":"24","author":[{"given":"Xiaomei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"1483_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417\u201329.","journal-title":"N Engl J Med"},{"key":"1483_CR2","first-page":"22529","volume":"8","author":"Y Ye","year":"2015","unstructured":"Ye Y, Pang Z, Chen W, Ju S, Zhou C. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8:22529\u201342.","journal-title":"Int J Clin Exp Med"},{"key":"1483_CR3","first-page":"33","volume":"6","author":"AE M\u2019Koma","year":"2013","unstructured":"M\u2019Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33\u201347.","journal-title":"Clin Med Insights Gastroenterol"},{"key":"1483_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3109\/00365521.2015.1014407","volume":"50","author":"J Burisch","year":"2015","unstructured":"Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942\u201351.","journal-title":"Scand J Gastroenterol"},{"key":"1483_CR5","doi-asserted-by":"crossref","unstructured":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.e42; quiz e30.","DOI":"10.1053\/j.gastro.2011.10.001"},{"key":"1483_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","volume":"145","author":"SC Ng","year":"2013","unstructured":"Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology. 2013;145:158-165.e2.","journal-title":"Gastroenterology"},{"key":"1483_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00535-017-1324-3","volume":"52","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, Chen B-L, Mao R, Zhang S-H, He Y, Zeng Z-R, et al. Systematic review with meta-analysis: loss of response and requirement of anti-TNF\u03b1 dose intensification in Crohn\u2019s disease. J Gastroenterol. 2017;52:535\u201354.","journal-title":"J Gastroenterol"},{"key":"1483_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/nu13041083","volume":"13","author":"M Bendix","year":"2021","unstructured":"Bendix M, Dige A, J\u00f8rgensen SP, Dahlerup JF, Bibby BM, Deleuran B, et al. Seven weeks of high-dose vitamin d treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn\u2019s disease during one-year follow-up. Nutrients. 2021;13:1083.","journal-title":"Nutrients"},{"key":"1483_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1159\/000502515","volume":"101","author":"N-C Mechie","year":"2020","unstructured":"Mechie N-C, Mavropoulou E, Ellenrieder V, Kunsch S, Cameron S, Amanzada A. Distinct association of serum vitamin D concentration with disease activity and trough levels of infliximab and adalimumab during inflammatory bowel disease treatment. Digestion. 2020;101:761\u201370.","journal-title":"Digestion"},{"key":"1483_CR10","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1097\/MPG.0000000000003064","volume":"72","author":"H Hizarcioglu-Gulsen","year":"2021","unstructured":"Hizarcioglu-Gulsen H, Kaplan JL, Moran CJ, Israel EJ, Lee H, Winter H. The impact of vitamin D on response to anti-tumor necrosis factor-\u03b1 therapy in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2021;72:e125\u201331.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1483_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015172","volume":"98","author":"N-C Mechie","year":"2019","unstructured":"Mechie N-C, Mavropoulou E, Ellenrieder V, Petzold G, Kunsch S, Neesse A, et al. Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease. Medicine (Baltimore). 2019;98: e15172.","journal-title":"Medicine (Baltimore)"},{"key":"1483_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/MIB.0000000000000697","volume":"22","author":"J Santos-Antunes","year":"2016","unstructured":"Santos-Antunes J, Nunes AC-R, Lopes S, Macedo G. The relevance of vitamin D and antinuclear antibodies in patients with inflammatory bowel disease under anti-TNF treatment: a prospective study. Inflamm Bowel Dis. 2016;22:1101\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"1483_CR13","first-page":"1026","volume":"5","author":"N Chanchlani","year":"2023","unstructured":"Chanchlani N, Lin S, Smith R, Roberts C, Nice R, McDonald TJ, et al. Pretreatment vitamin D concentrations do not predict therapeutic outcome to anti-TNF therapies in biologic-na\u00efve patients with active luminal Crohn\u2019s disease. Crohns Colitis 360. 2023;5:1026.","journal-title":"Crohns Colitis 360"},{"key":"1483_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23532","volume":"34","author":"L Li","year":"2020","unstructured":"Li L, Li K, Li J, Luo Y, Cheng Y, Jian M, et al. Ethnic, geographic, and seasonal differences of vitamin D status among adults in south-west China. J Clin Lab Anal. 2020;34: e23532.","journal-title":"J Clin Lab Anal"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"175628482312103","DOI":"10.1177\/17562848231210367","volume":"16","author":"J Wan","year":"2023","unstructured":"Wan J, Shen J, Wu X, Zhong J, Chen Y, Zhu L, et al. Geographical heterogeneity in the disease characteristics and management of patients with inflammatory bowel disease, the preliminary results of a Chinese database for IBD (CHASE-IBD). Therap Adv Gastroenterol. 2023;16:17562848231210368.","journal-title":"Therap Adv Gastroenterol"},{"key":"1483_CR16","doi-asserted-by":"crossref","unstructured":"Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis. 2021;22:298\u2013317.","DOI":"10.1111\/1751-2980.12994"},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"1483_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ibd\/izz143","volume":"26","author":"LE Bauman","year":"2020","unstructured":"Bauman LE, Xiong Y, Mizuno T, Minar P, Fukuda T, Dong M, et al. Improved population pharmacokinetic model for predicting optimized infliximab exposure in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:429\u201339.","journal-title":"Inflamm Bowel Dis"},{"key":"1483_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel J-F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u201353.","journal-title":"Gut"},{"key":"1483_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ecco-jcc\/jjy111","volume":"12","author":"K van Hoeve","year":"2018","unstructured":"van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, et al. Higher infliximab trough levels are associated with better outcome in paediatric patients with inflammatory bowel disease. J Crohns Colitis. 2018;12:1316\u201325.","journal-title":"J Crohns Colitis"},{"key":"1483_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u201344.","journal-title":"Gastroenterology"},{"key":"1483_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1053\/j.gastro.2019.06.038","volume":"157","author":"S Danese","year":"2019","unstructured":"Danese S, Sandborn WJ, Colombel J-F, Vermeire S, Glover SC, Rimola J, et al. Endoscopic, radiologic, and histologic healing with Vedolizumab in patients with active Crohn\u2019s disease. Gastroenterology. 2019;157:1007-1018.e7.","journal-title":"Gastroenterology"},{"key":"1483_CR23","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.3390\/jcm11195715","volume":"11","author":"A Szymczak-Tomczak","year":"2022","unstructured":"Szymczak-Tomczak A, Ratajczak AE, Kaczmarek-Ry\u015b M, Hryhorowicz S, Rychter AM, Zawada A, et al. Pleiotropic effects of vitamin D in patients with inflammatory bowel diseases. J Clin Med. 2022;11:5715.","journal-title":"J Clin Med"},{"key":"1483_CR24","doi-asserted-by":"publisher","first-page":"G341","DOI":"10.1152\/ajpgi.00105.2015","volume":"309","author":"S Wu","year":"2015","unstructured":"Wu S, Yoon S, Zhang Y-G, Lu R, Xia Y, Wan J, et al. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol. 2015;309:G341-349.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1483_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/gutjnl-2014-307436","volume":"64","author":"S Wu","year":"2015","unstructured":"Wu S, Zhang Y-G, Lu R, Xia Y, Zhou D, Petrof EO, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64:1082\u201394.","journal-title":"Gut"},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/0929867323666161026124951","volume":"24","author":"J Abdo","year":"2017","unstructured":"Abdo J, Rai V, Agrawal DK. Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy. Curr Med Chem. 2017;24:852\u201367.","journal-title":"Curr Med Chem"},{"key":"1483_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2017.04.010","volume":"453","author":"V Dimitrov","year":"2017","unstructured":"Dimitrov V, White JH. Vitamin D signaling in intestinal innate immunity and homeostasis. Mol Cell Endocrinol. 2017;453:68\u201378.","journal-title":"Mol Cell Endocrinol"},{"key":"1483_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/00365521.2020.1844793","volume":"56","author":"Y Yang","year":"2021","unstructured":"Yang Y, Cui X, Li J, Wang H, Li Y, Chen Y, et al. Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn\u2019s disease in the Chinese population. Scand J Gastroenterol. 2021;56:20\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"1483_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.crohns.2011.10.010","volume":"6","author":"K Ogawa","year":"2012","unstructured":"Ogawa K, Matsumoto T, Esaki M, Torisu T, Iida M. Profiles of circulating cytokines in patients with Crohn\u2019s disease under maintenance therapy with infliximab. J Crohns Colitis. 2012;6:529\u201335.","journal-title":"J Crohns Colitis"},{"key":"1483_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1080\/00365521.2017.1339825","volume":"52","author":"T Billiet","year":"2017","unstructured":"Billiet T, Cleynen I, Ballet V, Claes K, Princen F, Singh S, et al. Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn\u2019s disease. Scand J Gastroenterol. 2017;52:1086\u201392.","journal-title":"Scand J Gastroenterol"},{"key":"1483_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.739285","volume":"8","author":"S-L Xia","year":"2021","unstructured":"Xia S-L, Min Q-J, Shao X-X, Lin D-P, Ma G-L, Wu H, et al. Influence of vitamin D3 supplementation on infliximab effectiveness in Chinese patients with Crohn\u2019s disease: A retrospective cohort study. Front Nutr. 2021;8: 739285.","journal-title":"Front Nutr"},{"key":"1483_CR32","doi-asserted-by":"publisher","first-page":"6675401","DOI":"10.1155\/2023\/6675401","volume":"2023","author":"X Song","year":"2023","unstructured":"Song X, Zhang H, Wang H, Li Z, Zhou X, Guo H. Correlation between treatment outcomes and serum vitamin D levels as well as infliximab trough concentration among Chinese patients with Crohn\u2019s disease. Gastroenterol Res Pract. 2023;2023:6675401.","journal-title":"Gastroenterol Res Pract"},{"key":"1483_CR33","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/bcp.14648","volume":"87","author":"A-M Grisic","year":"2021","unstructured":"Grisic A-M, Eser A, Huisinga W, Reinisch W, Kloft C. Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease management. Br J Clin Pharmacol. 2021;87:2374\u201384.","journal-title":"Br J Clin Pharmacol"},{"key":"1483_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ajg.2016.53","volume":"111","author":"TA Kabbani","year":"2016","unstructured":"Kabbani TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, Shah N, Swoger J, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol. 2016;111:712\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1483_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/apt.13936","volume":"45","author":"RW Winter","year":"2017","unstructured":"Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR. Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-\u03b1 medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45:653\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1365-2133.2009.09563.x","volume":"162","author":"AE Pink","year":"2010","unstructured":"Pink AE, Fonia A, Allen MH, Smith CH, Barker JNWN. Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol. 2010;162:780\u20135.","journal-title":"Br J Dermatol"},{"key":"1483_CR37","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","volume":"21","author":"S Rodrigues","year":"2015","unstructured":"Rodrigues S, Lopes S, Magro F, Cardoso H, Horta e Vale AM, Marques M, et al. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases. World J Gastroenterol. 2015;21:7584\u20138.","journal-title":"World J Gastroenterol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01483-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T12:09:11Z","timestamp":1732968551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01483-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01483-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4677099\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"237"}}